Clinical trials recruiting in Lower Hutt, New Zealand

Phase breakdown

Conditions recruiting in Lower Hutt, New Zealand

Recruiting trials in Lower Hutt, New Zealand

• A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
  NCT06430801 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female)
• Alloplastic Total Temporomandibular Joint (TMJ) Replacement Registry
  NCT03991728 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
  NCT07184931 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female)
• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
  NCT07064473 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Lower Hutt, New Zealand?

4 recruiting trials have at least one study site in Lower Hutt, New Zealand.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.